Hide Board Information

Show Board Information

Fortis Inc. Ser E FTS.PR.E

Board Mod: Add me as mod

Asst Mods:

Last Post: 06/02/2012 6:26:36 AM

Board Marks: 0

Posts Today: 0

Board Views Today: 1

Fortis Inc. Ser E (FTS.PR.E) Stock Message Board

Find FTS.PR.E Recent News, FTS.PR.E Filings, FTS.PR.E Stock Quote, FTS.PR.E Stock Chart, FTS.PR.E Research & Opinions Below

Create New Post View All Posts Board Mark Banned

Post

Subject

Author

Posted On

Be the first to post on Fortis Inc. Ser E FTS.PR.E

Recent Articles

• Boehringer Ingelheim to Present Early Cancer Treatment Findings
• Columvi: Advances in DLBCL Treatment Show Promising Results
• Nyrstar NV Announces Key Details for Upcoming Shareholders' Meeting
• Insights from LHV Pank's Latest Analysis on EfTEN Real Estate Fund
• Roche Partners with Broad Clinical Labs to Transform Genomics
• Hisense Integrates Google Home APIs for Smart Home Expansion
• Shareholder Meeting Announcement: EVS Expands Communication Efforts
• Mowi ASA Announces Ex-Dividend of NOK 1.70 to Shareholders
• Aurio Launches Finance Operations to Empower Business Growth
• Nona Biosciences Collaborates with Pfizer to Advance MesoC2
• Antengene Unveils Promising Data on Groundbreaking Cancer Treatments
• SUNMI Launches Innovative Store Concept in Atlanta's Hub
• Chenbro Displays Innovative AI Server Solutions at Key Event
• Laurent-Perrier Reveals Financial Results for 2024-2025
• Volvo Trucks Driver Challenge: Inspiring Sustainable Driving
• ProCap Acquisition Corp Completes $250 Million IPO Successfully
• FDA Approves IND for Innovative Cancer Treatment AVZO-1418
• Global Recognition for Deqing's Aquaculture Legacy in Farming
• Unveiling Global Impressions: China's Infrastructure Story
• Exploring the Future of Self-Driving Cars Industry by 2032
• Brompton Split Banc Corp. Unveils Renewed Equity Program
• Think Together Names Matt Scharpnick as Chief Innovation Officer
• Algernon Pharmaceuticals Secures Acquisition of NoBrainer Imaging
• Gyre Therapeutics Sets Public Offering at $20 Million for Growth
• Exciting Clinical Insights on Ascentage Pharma's Lisaftoclax
• Investigation Launched into Ibotta, Inc. Shareholder Concerns
• Hidrovias International Finance Unlocks Tender Offer Success
• Transforming Aging: Innovations from the Canton Fair
• ZEBRA Unveils New Non-Toxic Lip Gloss for Beauty Enthusiasts
• Exciting HUTCHMED Clinical Advances Highlighted at ASCO 2025
• CARsgen's Innovative Satri-cel Gains Recognition at ASCO
• GNTbm Enhances Cancer Immunotherapy with GNTbm-38's Advancements
• E7386's Promising Role in Combination Therapy for Cancer
• Exploring Legal Options for Viatris Investors Amid Concerns
• AI-Media and Lightning International Redefine Global Entertainment
• Revolutionizing Healthcare: MindHYVE.ai™ Partners for AI Diagnostic Leap
• Reeflex Solutions Inc. Completes Milestone Transaction Successfully
• Exploring Pixalate's Q1 2025 Ad Viewability Standards Across APAC
• Swiss Water Decaffeinated Coffee Unveils AGM Voting Outcomes
• Imperial Metals Reports Successful Director Elections Outcome
• NEDHSA's Groundbreaking Research in Integrated Care Models
• Rakuten Medical Expands Global Enrollment for Clinical Trials
• Frontera Energy Corporation Celebrates Shareholder Votes
• Dubai's Culinary Scene Thrives with Two Restaurants Winning Big
• Mullen Group Ltd. Secures Major Funding through Notes Offering
• Bunker Hill Mining Corp. Secures Funding Through Note Increase
• Jack Henry's CEO Greg Adelson Highlights Business Strategy
• Discover the Best New Online Casinos in the U.S for 2025
• The Coastal Companies Voluntary Recall of Potentially Contaminated Foods
• Exciting Developments at Vortex Energy Corp. Through LIFE Financing